Marker Therapeutics, Inc. (MRKR)
1.42
-0.04
(-2.74%)
USD |
NASDAQ |
May 15, 16:00
1.44
+0.02
(+1.41%)
After-Hours: 20:00
Marker Therapeutics Total Liabilities (Quarterly) : 3.638M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | 28.88M |
| Krystal Biotech, Inc. | 120.24M |
| Neurocrine Biosciences, Inc. | 1.499B |
| Agenus, Inc. | 414.44M |
| Curis, Inc. | 16.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.43M |
| Shareholders Equity (Quarterly) | 13.80M |
| Current Ratio | 4.792 |